[Clinical features and FGFR3 mutations of children with achondroplasia]

Zhongguo Dang Dai Er Ke Za Zhi. 2022 Apr 15;24(4):405-410. doi: 10.7499/j.issn.1008-8830.2111039.
[Article in Chinese]

Abstract

Objectives: To study the clinical features and fibroblast growth factor receptor 3 (FGFR3) gene mutations of children with achondroplasia (ACH) through an analysis of 17 cases.

Methods: A retrospective analysis was performed on the clinical data and FGFR3 gene detection results of 17 children with ACH who were diagnosed from January 2009 to October 2021.

Results: Of the 17 children with ACH, common clinical manifestations included disproportionate short stature (100%, 17/17), macrocephaly (100%, 17/17), trident hand (82%, 14/17), and genu varum (88%, 15/17). The common imaging findings were rhizomelic shortening of the long bones (100%, 17/17) and narrowing of the lumbar intervertebral space (88%, 15/17). Major complications included skeletal dysplasia (100%, 17/17), middle ear dysfunction (82%, 14/17), motor/language developmental delay (88%, 15/17), chronic pain (59%, 10/17), sleep apnea (53%, 9/17), obesity (41%, 7/17), foramen magnum stenosis (35%, 6/17), and hydrocephalus (24%, 4/17). All 17 children (100%) had FGFR3 mutations, among whom 13 had c.1138G>A hotspot mutations of the FGFR3 gene, 2 had c.1138G>C mutations of the FGFR3 gene, and 2 had unreported mutations, with c.1252C>T mutations of the FGFR3 gene in one child and c.445+2_445+5delTAGG mutations of the FGFR3 gene in the other child.

Conclusions: This study identifies the unreported mutation sites of the FGFR3 gene, which extends the gene mutation spectrum of ACH. ACH is a progressive disease requiring lifelong management through multidisciplinary collaboration.

目的: 分析17例软骨发育不全(achondroplasia,ACH)患儿的临床特征及成纤维细胞生长因子受体3(fibroblast growth factor receptor 3,FGFR3)基因变异情况。方法: 回顾性分析2009年1月至2021年10月确诊的17例ACH患儿临床资料及FGFR3基因检测结果。结果: ACH最常见的临床表现是不匀称型身材矮小(100%,17/17)、大头畸形(100%,17/17)、三叉戟手畸形(82%,14/17)、膝内翻(88%,15/17)。最普遍的影像学是根茎状长骨缩短(100%,17/17)和腰椎椎间距变窄(88%,15/17)。主要并发症有骨骼异常(100%,17/17)、中耳功能障碍(82%,14/17)、运动及语言发育迟缓(88%,15/17)、慢性疼痛(59%,10/17)、睡眠呼吸暂停(53%,9/17)、肥胖(41%,7/17)、枕骨大孔缩小(35%,6/17)、脑积水(24%,4/17)。17例(100%)均存在FGFR3基因变异,13例为FGFR3基因c.1138G>A的热点突变;2例FGFR3基因c.1138G>C变异;2例为未报道的变异,其中1例FGFR3基因c.1252C>T变异,1例FGFR3基因c.445+2_445+5delTAGG变异。结论: 该研究检出FGFR3基因未报道变异位点,扩展了ACH基因变异谱。ACH是一种进行性发展的疾病,其相关并发症由多学科团队协作进行终身管理。.

Keywords: Achondroplasia; Child; Fibroblast growth factor receptor 3 gene; Gene mutation.

MeSH terms

  • Achondroplasia* / diagnosis
  • Achondroplasia* / genetics
  • Child
  • Humans
  • Mutation
  • Osteochondrodysplasias / genetics
  • Receptor, Fibroblast Growth Factor, Type 3* / genetics
  • Retrospective Studies

Substances

  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3